AV

Ande Venkata Siva Sai Abhinav

Active Director Director DIN 11158103
DIN 11158103 First appointment Jun 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Ande Venkata Siva Sai Abhinav

Data last updated:

Ande Venkata Siva Sai Abhinav is a Director at Opinor Health Private Limited (since 2025). The company operates in Healthcare.

DIN 11158103
Primary Designation Director
Industry Healthcare
First Appointment 17 Jun 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Opinor Health Private Limited U21001AP2025PTC119870
Director17 Jun 20252025Active

Board colleagues of Ande Venkata Siva Sai Abhinav

NameDINCompanyDesignation
Venkateswararao Ande11158104Opinor Health Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Opinor Health Private Limited
Premium access

Shareholding and investment profile for Ande Venkata Siva Sai Abhinav

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ande Venkata Siva Sai Abhinav

Ande Venkata Siva Sai Abhinav currently holds 1 directorship: Opinor Health Private Limited (Director, since 17 Jun 2025).

Ande Venkata Siva Sai Abhinav was first appointed on 17 Jun 2025 as Director at Opinor Health Private Limited.

The current boards of Ande Venkata Siva Sai Abhinav's companies include Venkateswararao Ande (Opinor Health Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available